Pacira BioSciences, Inc. Form SCHEDULE 13D/A — Oct 13, 2026
The DOMA Perpetual group filed Amendment No. 4 to its Schedule 13D on Pacira BioSciences, reporting that as of October 8, 2026 it ceased to be a beneficial owner of more than 5% of the company's common shares. On October 8, 2026, the group sold approximately 2.94 million shares in open-market transactions at $36.29 per share, including 1,965,765 shares by the Doma Master Fund, 812,019 shares by the John Templeton Foundation, and 159,000 shares by Pedro Escudero.
Key figures
- Shares Outstanding
- 39861886
- Exit date
- 2026-10-08
- Percent owned
- 0%
- Sale price per share
- $36.29
- Shares sold escudero
- 159000
- Shares sold master fund
- 1965765
- Shares sold templeton foundation
- 812019
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.